- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Nikhil Chopra to now spearhead JB Chemicals, appointed as Director, CEO
New Delhi: Former Cipla India Business Head, Nikhil Chopra, will now lead J B Chemicals & Pharmaceuticals as its's board has appointed him as Whole-time Director and Chief Executive Officer of the company.
"The board of directors of the company has appointed Chopra as Whole-time Director and CEO for a period of five years," J B Chemicals & Pharmaceuticals said in a filing to the BSE.
Prior to joining the company, Chopra worked as Head-India Business at Cipla Ltd, it added.
With a 24 years stint at Cipla since 1996, Chopra had been instrumental in integrating the generics business, worth around Rs 6000 crore. He had played a key role in Cipla's initiative of "Go Beyond the Pill" through patient awareness and facilitating low-cost diagnostic options in respiratory treatment.
He had played important role in integrating around 20 businesses of the company into 4 major clusters.
Also Read: Mega Exit: Cipla India Top Boss, 2 Senior Executives Step Out After 24 Year Stint
Chopra has over 20 years of experience backed up with a consistent record of sustainable growth and shareholder value creation, the filing said.
He holds M.Sc. in Organic Chemistry from Gujarat University, reports PTI.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751